S.lab (soloways)
Clinical trials sponsored by S.lab (soloways), explained in plain language.
-
New injection aims to retrain immune cells to fight arthritis
Disease control CompletedThis early study tested a new drug called EF-M2 (Immutalon) in 48 adults with moderate-to-severe rheumatoid arthritis. The drug is designed to shift immune cells from a pro-inflammatory to an anti-inflammatory state. Participants received injections for 4 weeks, and researchers m…
Phase: PHASE1, PHASE2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a protein derived from vitamin d tame chronic inflammation?
Disease control CompletedThis study tested a protein called GcMAF, which is made from vitamin D-binding protein and is thought to calm the immune system. Researchers gave it to 120 adults with chronic inflammatory conditions like rheumatoid arthritis or cystitis that didn't improve with standard treatmen…
Phase: PHASE1, PHASE2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New group therapy shows promise for easing anxiety and depression
Symptom relief CompletedThis study tested a new type of group therapy called Terebenin's Method for adults with mild to moderate anxiety and depression. The therapy combines role-playing, body awareness, and guided discussion in weekly sessions over 8 weeks. Researchers measured changes in symptoms and …
Phase: NA • Sponsor: S.LAB (SOLOWAYS) • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC